We welcome new client Henogen S.A in Belgium. Henogen, a spin-off from the Université Libre de Bruxelles (ULB) in 2000, became a pharmaceutical company in its own right in 2002. The company's speciality is transplants. It has three original medicines (biotechnology origin) at various stages of clinincal development, with two production centres, in Gosselies and Seneffe.